Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation.
Serkan CayMeryem KaraFirat OzcanOzcan OzekeTolga AksuDursun ArasSerkan TopalogluPublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2022)
Propafenone use after AF ablation in patients with mild to moderate CAD had a safety profile similar to amiodarone and was not associated with major arrhythmic events.
Keyphrases
- atrial fibrillation
- coronary artery disease
- catheter ablation
- patients undergoing
- percutaneous coronary intervention
- left atrial
- left atrial appendage
- oral anticoagulants
- cardiovascular events
- coronary artery bypass grafting
- radiofrequency ablation
- heart failure
- direct oral anticoagulants
- cardiovascular disease
- type diabetes
- acute coronary syndrome